Lido Advisors’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
VCM
VPM
DAM
Lido Advisors's RMD Position: Q1 2026 in Review
Lido Advisors reduced its ResMed (RMD) stake by 36% in Q1 2026, selling an estimated $399K and leaving 2,816 shares worth $632K. The position accounts for ﹤0.01% of the portfolio, ranked #1177.
Lido Advisors first reported a position in RMD in Q2 2020 and has held it in 21 quarters since. The position peaked at $1.23M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Lido Advisors held 2,816 shares of ResMed worth $632K as of Q1 2026.
- Lido Advisors sold 1,603 ResMed shares in Q1 2026, an estimated $399K.
- ResMed made up ﹤0.01% of Lido Advisors's portfolio in Q1 2026, its #1177 holding.
- Lido Advisors first reported a position in ResMed in Q2 2020 and has held it in 21 quarters since.
- Lido Advisors's ResMed position peaked at $1.23M in Q3 2025.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Lido Advisors's 13F filing for Q1 2026, filed 13 May 2026.